1Mo·

Atai Life Science

Let's see where the journey takes us 😉 I actually wanted to join in June, but didn't dare 👎

20.10

Atai Beckley N.V

Acheté x167 à 5,97 €

996,99 €

15 Commentaires

Novius@Novius

1Mo

As far as I know, >80% of all drug and therapy developments fail on the way to approval. That's too big a risk for me personally. Nevertheless, good luck 👍🏽

•

Basti92@BavarianLion

1Mo

@Novius This investment cannot be justified rationally, but is simply a "gamble"! I have a solid portfolio and sometimes a gamble like this can also bring good money! 😉

•

Chris@Multibagger

1Mo

@Novius That's true, but the other 20% is crucial. That is why it is important to have the largest possible fully financed development platform.

•

jkb92@jkb92

1Mo

@Novius https://de.marketscreener.com/boerse-nachrichten/atai-life-sciences-n-v-und-beckley-psytech-us-fda-erteilt-bpl-003-den-status-als-breakthrough-th-ce7d5adcd18bf722

••

Novius@Novius

1Mo

@Multibagger Platform or pipeline? In my opinion, betting on a candidate with one arrow in its quiver is like playing black or red roulette. I prefer the established pharmaceutical companies with several arrows in their quiver, even if the returns are more "boring". On the other hand, one corpse in my portfolio is such an established pharmaceutical company: Novo Nordisk 😅

•

jkb92@jkb92

1Mo

@Multibagger Are you also invested?

•

All-in-or-nothing@All-in-or-nothing

1Mo

@jkb92 I'm in🙃.

•

Chris@Multibagger

1Mo

@jkb92 yepp

•

Chris@Multibagger

1Mo

@Novius Pipeline of course

•

Basti92@BavarianLion

1Mo

@Multibagger I would be interested to know how you become aware of such "smaller" stocks? You really have an extremely good hand with small caps and often get 200-300% out of them! 💪

•

Chris@Multibagger

1Mo

@BavarianLion I sometimes ask myself that too!😂 All joking aside, I think with many stocks it's simply the unconventional approach. In the case of commodity stocks, it's more likely to be the reading of paid stock reports. Otherwise I wouldn't be able to get my hands on some companies.
For the others, I generally read a lot here and in other publications (no Facebook, WhatsApp or Instagram groups), but the real art is to pick the right ones from the multitude. That doesn't always work. But I stick very consistently to my return expectations and quickly sell the ones that don't perform as hoped. Sometimes with a small profit, sometimes with a small loss, but neither is significant. And when I'm right, things just work out. Nobody is always right. Success lies in recognizing this early on, admitting it to yourself and acting accordingly.
If you read my posts here about other ideas, especially from @Tenbagger2024, who I really appreciate for his many company ideas, you will see that I often write that I don't see an investment because I don't see the 5% monthly return opportunity. That is one of the reasons for the relatively large number of 100 and more %ers.

•

Voir toutes les 3 autres réponses

Lelija@Lel1ja

1Mo

👍 also with us since 2023.
Lots of potential and risk included.

•